In Vivo Mapping of Myocardial Injury Outside the Infarct Zone: Tissue at an Intermediate Pathological State.

Area of Science:

• Cardiovascular Imaging
• Molecular Cardiology
• Biomedical Engineering

Background:

• Assessing the intermediate zone of injured-but-not-infarcted myocardium is critical for understanding post-ischemic heart disease.
• Current imaging techniques may not adequately differentiate this pathophysiologically distinct tissue from normal or infarcted regions.

Purpose of the Study:

• To evaluate the feasibility of using 99mTc-duramycin for in vivo mapping of the injured-but-not-infarcted myocardium.
• To characterize this intermediate tissue zone and its contribution to cardiac dysfunction.

Main Methods:

• Coronary artery ligation was performed in Sprague Dawley rats to induce myocardial ischemia.
• In vivo single-photon emission computed tomography (SPECT) imaging was conducted using 99mTc-duramycin.
• Gene expression profiling and echocardiography were used to assess tissue characteristics and cardiac function.

Main Results:

• 99mTc-duramycin SPECT successfully identified infarct and a distinct intermediate tissue zone.
• The intermediate tissue showed heterogeneous pathological changes and a smaller volume than the area-at-risk.
• Gene expression analysis revealed a higher prosurvival ratio in the intermediate zone compared to infarct tissue.
• Cardiac function measurements at 4 weeks post-ischemia showed decreased contractility.

Conclusions:

• 99mTc-duramycin-based imaging is feasible for in vivo mapping of the injured-but-not-infarcted myocardium.
• This intermediate tissue zone, characterized by specific molecular and cellular changes, significantly contributes to post-ischemic cardiac dysfunction.